Literature DB >> 18656386

Supratentorial cavernous angiomas presenting with seizures: surgical outcomes in 60 consecutive patients.

Je Young Yeon1, Jong-Soo Kim, Su Jung Choi, Dae-Won Seo, Seung Bong Hong, Seung-Chyul Hong.   

Abstract

The aim of this study is to determine surgical outcomes and factors affecting seizure outcomes in patients who harbor supratentorial cavernous angiomas presenting with seizures. Sixty patients were classified into the intractable epilepsy group (n=22) and the sporadic seizure group (n=38) and then managed differently in accordance with our guidelines. Patients exhibiting sporadic seizures were treated by lesionectomy, except for patients harboring mesial temporal lesions. We performed lesionectomy, extended lesionectomy, standard temporal lobectomy and tailored resection on 33, 9, 9 and 9 patients, respectively. Finally, 72.7% (16/22) of patients with intractable epilepsy and 89.5% (34/38) of patients with sporadic seizures achieved Engel Class I outcomes. A long duration of illness was somewhat related to a poor outcome in patients with intractable epilepsy, yet this was not true of patients with sporadic seizures. Other factors which included age at onset, size of the lesions and locations were not related to seizure outcomes. The role of residual hemosiderin is yet to be discovered. A lesionectomy alone can be considered a reasonable approach for those patients who exhibit sporadic seizures and have an extra-temporal or neo-temporal lesion. In patients with intractable epilepsy and/or mesial temporal lesions, a more invasive approach could achieve the better seizure outcome.

Entities:  

Mesh:

Year:  2008        PMID: 18656386     DOI: 10.1016/j.seizure.2008.05.010

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  18 in total

1.  Surgery for epilepsy.

Authors:  Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

Review 2.  Should we resect peri-lesional hemosiderin deposits when performing lesionectomy in patients with cavernoma-related epilepsy (CRE)?

Authors:  P Dammann; C Schaller; U Sure
Journal:  Neurosurg Rev       Date:  2016-11-08       Impact factor: 3.042

Review 3.  Emerging Use of Ultra-High-Field 7T MRI in the Study of Intracranial Vascularity: State of the Field and Future Directions.

Authors:  J W Rutland; B N Delman; C M Gill; C Zhu; R K Shrivastava; P Balchandani
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

4.  Safety and effectiveness of stereotactic laser ablation for epileptogenic cerebral cavernous malformations.

Authors:  Jon T Willie; James G Malcolm; Matthew A Stern; Lindsay O Lowder; Stewart G Neill; Brian T Cabaniss; Daniel L Drane; Robert E Gross
Journal:  Epilepsia       Date:  2019-01-17       Impact factor: 5.864

5.  Patient-assessed satisfaction and outcome after microsurgical resection of cavernomas causing epilepsy.

Authors:  Jamie J Van Gompel; W Richard Marsh; Fredric B Meyer; Gregory A Worrell
Journal:  Neurosurg Focus       Date:  2010-09       Impact factor: 4.047

6.  Cavernous malformations of the central nervous system (CNS) in children: clinico-radiological features and management outcomes of 36 cases.

Authors:  Burcak Bilginer; Firat Narin; Sahin Hanalioglu; Kader Karlı Oguz; Figen Soylemezoglu; Nejat Akalan
Journal:  Childs Nerv Syst       Date:  2014-05-31       Impact factor: 1.475

Review 7.  Rates and predictors of seizure freedom in resective epilepsy surgery: an update.

Authors:  Dario J Englot; Edward F Chang
Journal:  Neurosurg Rev       Date:  2014-02-05       Impact factor: 3.042

8.  Magnetic Resonance Thermometry-Guided Stereotactic Laser Ablation of Cavernous Malformations in Drug-Resistant Epilepsy: Imaging and Clinical Results.

Authors:  D Jay McCracken; Jon T Willie; Brad A Fernald; Amit M Saindane; Daniel L Drane; Daniel L Barrow; Robert E Gross
Journal:  Oper Neurosurg (Hagerstown)       Date:  2015-09-25       Impact factor: 2.703

9.  Surgical management of cavernous malformations presenting with drug-resistant epilepsy.

Authors:  Mario Arturo Alonso-Vanegas; José M Cisneros-Franco; Taisuke Otsuki
Journal:  Front Neurol       Date:  2012-01-03       Impact factor: 4.003

10.  The Role of Hemosiderin Excision in Seizure Outcome in Cerebral Cavernous Malformation Surgery: A Systematic Review and Meta-Analysis.

Authors:  Di Ruan; Xiao-Bo Yu; Sudeep Shrestha; Lin Wang; Gao Chen
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.